£3.5M
Sartorius took a minority shareholding in the London startup through its corporate venture unit to support product commercialisation.
SB
SPARTA Biodiscovery
SPARTA Biodiscovery provides analytical technology for characterising nanoparticles used in vaccines and gene therapies.
White City, London, UK—Founded 2022
£3.5MTotal raised
SPARTA Biodiscovery is a spin-out from Imperial College London that develops analytical platforms for characterising nanoparticles used in advanced medicines. Its technology uses Raman spectroscopy to analyse single particles rapidly and automatically.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from SPARTA Biodiscovery's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Jelle Penders
CEO
Jelle serves as chief executive officer and founder of SPARTA Biodiscovery, alongside holding an honorary research associate role at Imperial College London.
LinkedInMS
Molly Stevens
Professor
Investors
S
SartoriusLead